BIO-TECHNE Corp Quarterly Interest Expense in USD from Q3 2013 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
BIO-TECHNE Corp quarterly/annual Interest Expense history and growth rate from Q3 2013 to Q1 2024.
  • BIO-TECHNE Corp Interest Expense for the quarter ending March 31, 2024 was $4.01M, a 193% increase year-over-year.
  • BIO-TECHNE Corp Interest Expense for the twelve months ending March 31, 2024 was $16.9M, a 69% increase year-over-year.
  • BIO-TECHNE Corp annual Interest Expense for 2023 was $11.2M, a 0.83% decline from 2022.
  • BIO-TECHNE Corp annual Interest Expense for 2022 was $11.3M, a 18.9% decline from 2021.
  • BIO-TECHNE Corp annual Interest Expense for 2021 was $14M, a 27.3% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $16.9M $4.01M +$2.64M +193% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $14.3M $4.33M +$1.97M +83.7% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-07
Q3 2023 $12.3M $4.89M +$1.1M +29.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $11.2M $3.7M +$1.2M +47.8% Apr 1, 2023 Jun 30, 2023 10-K 2023-08-23
Q1 2023 $10M $1.37M -$1.13M -45.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $11.1M $2.36M -$546K -18.8% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-07
Q3 2022 $11.7M $3.79M +$381K +11.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $11.3M $2.51M -$786K -23.9% Apr 1, 2022 Jun 30, 2022 10-K 2023-08-23
Q1 2022 $12.1M $2.49M -$167K -6.28% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $12.3M $2.9M -$683K -19.1% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-07
Q3 2021 $12.9M $3.41M -$1.01M -22.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $14M $3.29M -$1.33M -28.7% Apr 1, 2021 Jun 30, 2021 10-K 2023-08-23
Q1 2021 $15.3M $2.66M -$1.83M -40.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $17.1M $3.59M -$1.29M -26.4% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-07
Q3 2020 $18.4M $4.42M -$806K -15.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $19.2M $4.62M -$977K -17.5% Apr 1, 2020 Jun 30, 2020 10-K 2022-08-24
Q1 2020 $20.2M $4.49M -$627K -12.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $20.8M $4.87M -$887K -15.4% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-08
Q3 2019 $21.7M $5.22M -$17K -0.32% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $21.7M $5.59M +$2.54M +83.2% Apr 1, 2019 Jun 30, 2019 10-K 2021-08-25
Q1 2019 $19.2M $5.11M +$2.55M +99.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $16.6M $5.76M +$3.43M +147% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-06
Q3 2018 $13.2M $5.24M +$3M +134% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $10.2M $3.05M +$1.12M +58.1% Apr 1, 2018 Jun 30, 2018 10-K 2020-08-26
Q1 2018 $9.07M $2.56M +$452K +21.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $8.61M $2.33M +$410K +21.3% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-07
Q3 2017 $8.2M $2.24M +$843K +60.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 $7.36M $1.93M +$1.48M +330% Apr 1, 2017 Jun 30, 2017 10-K/A 2019-11-06
Q1 2017 $5.88M $2.11M +$1.66M +371% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $4.22M $1.92M +$1.52M +380% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-08
Q3 2016 $2.7M $1.4M +$949K +210% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $1.75M $449K +$67K +17.5% Apr 1, 2016 Jun 30, 2016 10-K 2018-08-27
Q1 2016 $1.68M $448K +$34K +8.21% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $1.65M $400K -$37K -8.47% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 $1.68M $451K +$140K +45% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $1.54M $382K Apr 1, 2015 Jun 30, 2015 10-K 2017-09-07
Q1 2015 $414K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 $437K +$437K Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-09
Q3 2014 $311K +$311K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q4 2013 $0 Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-09
Q3 2013 $0 Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.